Michael S. Saag
Impact in
- Virology top 0.01%
- HIV Research and Treatment
- Infectious Diseases top 0.01%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- Antifungal resistance and susceptibility
Papers in
-
- HIV/AIDS drug development and treatment 101
- HIV/AIDS Research and Interventions 95
- Virology 93
- HIV Research and Treatment 93
- Co-authors
- George M. Shaw (22 shared papers)Michael J. Mugavero (77 shared papers)J Michael Kilby (18 shared papers)Paul A. Volberding (18 shared papers)Donna M. Jacobsen (15 shared papers)Melanie Thompson (16 shared papers)Beatrice H. Hahn (16 shared papers)John C. Kappes (7 shared papers)
- Journals
- Clinical Infectious Diseases (31 papers)AIDS Research and Human Retroviruses (31 papers)AIDS (29 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (26 papers)The Journal of Infectious Diseases (13 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Michael S. Saag
322 papers receiving 28.8k citations
Michael S. Saag's Hit Papers
Peers
Comparison fields: 5 of 170
- Virology 12.3k
- Infectious Diseases 16.5k
- Emergency Medicine 3.6k
- Epidemiology 7.8k
- Hepatology 1.5k
Countries citing papers authored by Michael S. Saag
This map shows the geographic impact of Michael S. Saag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Saag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Saag more than expected).
Fields of papers citing papers by Michael S. Saag
This network shows the impact of papers produced by Michael S. Saag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Saag. The network helps show where Michael S. Saag may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael S. Saag, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 329 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antibody neutralization and escape by HIV-1 Hit paper breakdown → | 2003 | 1911 |
| 2 | Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy Hit paper breakdown → | 2002 | 1350 |
| 3 | Antiretroviral Therapy in Adults Hit paper breakdown → | 2000 | 891 |
| 4 | Antiretroviral Therapy for HIV Infection in 1998 Hit paper breakdown → | 1998 | 853 |
| 5 | Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry Hit paper breakdown → | 1998 | 851 |
| 6 | Treatment for Adult HIV Infection Hit paper breakdown → | 2006 | 791 |
| 7 | Treatment of Cryptococcal Meningitis Associated with the Acquired Immunodeficiency Syndrome Hit paper breakdown → | 1997 | 629 |
| 8 | Treatment for Adult HIV Infection Hit paper breakdown → | 2004 | 614 |
| 9 | Antiretroviral Treatment for Adult HIV Infection in 2002 Hit paper breakdown → | 2002 | 585 |
| 10 | Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. Hit paper breakdown → | 2006 | 560 |
| 11 | High Titers of Cytopathic Virus in Plasma of Patients with Symptomatic Primary HIV-1 Infection Hit paper breakdown → | 1991 | 549 |
| 12 | Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV Hit paper breakdown → | 1994 | 530 |
| 13 | Comparison of Amphotericin B with Fluconazole in the Treatment of Acute AIDS-Associated Cryptococcal Meningitis Hit paper breakdown → | 1992 | 520 |
| 14 | Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults Hit paper breakdown → | 2016 | 497 |
| 15 | 1996 | 420 | |
| 16 | Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults Hit paper breakdown → | 2018 | 415 |
| 17 | 1995 | 413 | |
| 18 | 2008 | 405 | |
| 19 | 2005 | 396 | |
| 20 | Antiretroviral Treatment of Adult HIV Infection Hit paper breakdown → | 2014 | 372 |
About Michael S. Saag
Michael S. Saag is a scholar working on Infectious Diseases, Virology, Emergency Medicine, Epidemiology and Hepatology, having authored 329 papers that have together received 30.2k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (101 papers), HIV/AIDS Research and Interventions (95 papers), HIV Research and Treatment (93 papers), HIV-related health complications and treatments (64 papers), Hepatitis C virus research (21 papers), HIV, Drug Use, Sexual Risk (17 papers), Immune Cell Function and Interaction (13 papers) and Pneumocystis jirovecii pneumonia detection and treatment (12 papers). The work is most often cited by research in Virology (12.3k citations), Infectious Diseases (16.5k citations), Emergency Medicine (3.6k citations), Epidemiology (7.8k citations) and Hepatology (1.5k citations). Michael S. Saag has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include George M. Shaw, Michael J. Mugavero, J Michael Kilby, Paul A. Volberding, Donna M. Jacobsen, Melanie Thompson, Beatrice H. Hahn, John C. Kappes, Douglas D. Richman and Xiping Wei. Their work appears in journals such as Clinical Infectious Diseases, AIDS Research and Human Retroviruses, AIDS, JAIDS Journal of Acquired Immune Deficiency Syndromes and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.